Latest news with #TomGodfrey
Business Insider
16-06-2025
- Business
- Business Insider
Ord Minnett Remains a Buy on Regis Healthcare Ltd. (REG)
Ord Minnett analyst Tom Godfrey maintained a Buy rating on Regis Healthcare Ltd. (REG – Research Report) today and set a price target of A$8.25. The company's shares opened today at A$7.36. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Godfrey is a 3-star analyst with an average return of 7.9% and a 36.73% success rate. Godfrey covers the Healthcare sector, focusing on stocks such as Monash IVF Group Ltd, Sigma Healthcare Ltd, and EBOS Group Limited. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Regis Healthcare Ltd. with a A$8.93 average price target, representing a 21.33% upside. In a report released on June 5, Jefferies also maintained a Buy rating on the stock with a A$8.80 price target.
Business Insider
21-05-2025
- Business
- Business Insider
Ord Minnett Sticks to Its Buy Rating for Monash IVF Group Ltd (MVF)
In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Monash IVF Group Ltd (MVF – Research Report), with a price target of A$1.05. The company's shares opened today at A$0.75. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter According to TipRanks, Godfrey is ranked #1853 out of 9519 analysts. In addition to Ord Minnett, Monash IVF Group Ltd also received a Buy from Macquarie's Rachael Harwood in a report issued today. However, yesterday, RBC Capital maintained a Hold rating on Monash IVF Group Ltd (ASX: MVF). The company has a one-year high of A$1.47 and a one-year low of A$0.68. Currently, Monash IVF Group Ltd has an average volume of 2.19M.
Business Insider
08-05-2025
- Business
- Business Insider
Ord Minnett Sticks to Their Buy Rating for 4DMedical Ltd (4DX)
Ord Minnett analyst Tom Godfrey maintained a Buy rating on 4DMedical Ltd (4DX – Research Report) today and set a price target of A$0.76. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Godfrey is ranked #1741 out of 9472 analysts. Currently, the analyst consensus on 4DMedical Ltd is a Moderate Buy with an average price target of A$0.70. Based on 4DMedical Ltd's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$2.9 million and a GAAP net loss of A$19.17 million. In comparison, last year the company earned a revenue of A$792.51 thousand and had a GAAP net loss of A$15.61 million
